drugset / Trial / NCT03733249
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
NaSingle-groupOpen-labelTreatment
Summary
This is a long-term follow up study evaluating the safety of BPX-501 T cells (rivogenlecleucel) and infused in pediatric patients previously enrolled on the BP-004 study.
Timeline
- Start
- 2017-01
- Primary completion
- 2020-06-30
- Completion
- 2023-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rivogenlecleucel | Cell therapy | — | — |
| Background | Rimiducid | Other / unclassified | 0.4 mg/kg | Intravenous |